AUDUBON, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a number one musculoskeletal options firm, introduced five-year outcomes from the NuVasive Simplify Cervical Disc examine on the North American Backbone Society (NASS) 38th Annual Assembly. The examine demonstrates optimistic, long-term scientific outcomes, a excessive fee of total composite success at 60 months, and statistical superiority to anterior cervical discectomy fusion (ACDF) procedural outcomes.
“Having clinically backed, long-term information for the Simplify Cervical Disc validates the promising scientific information we noticed Simplify having on the two-year mark,” mentioned Kyle Malone, senior vice chairman, Scientific Affairs of Globus Medical. “We’ll proceed to innovate throughout the cervical spine phase offering industry-leading, procedural options clinically designed to ship higher outcomes for sufferers.”
The five-year Simplify Cervical Disc examine* discovered:
- Simplify Cervical Disc was statistically superior to the ACDF management by way of total composite success at 5 years,
- Statistically vital postoperative enhancements in neck incapacity index (NDI) and visible analog scale (VAS) (mixed neck and arm ache) discovered at two years have been maintained by means of 5 years, with the Simplify Cervical Disc group having considerably decrease NDI and VAS scores at 5 years when in comparison with the ACDF management,
- Common disc top and flexion/extension vary of movement elevated postoperatively within the Simplify Disc group and remained above preoperative ranges all through follow-up, and
- No system failures have been reported within the Simplify Disc group.
Dr. Pierce Nunley of the Backbone Institute of Louisiana expressed his enthusiasm in regards to the sturdiness of the optimistic outcomes noticed at 24 months. He said, “I’m wanting to witness the continued success of those outcomes past the 60-month mark. This examine additional reinforces that Simplify is an impressive motion-preserving answer with enduring scientific benefits over ACDF.”
*Information on file.
Simplify Cervical Disc shouldn’t be but obtainable in all international locations. Please confer with the Simplify Disc IFU and Affected person Labeling for necessary product data, together with however not restricted to, Indications, Contraindications, Warnings, Precautions, Dangers and Potential Hostile Results. The IFU and Affected person Labeling might be discovered right here.
About Globus Medical, Inc.
Globus Medical is dedicated to offering modern applied sciences and industry-leading scientific assist to assist surgeons and healthcare suppliers ship higher care across the globe. The Firm offers one of the complete choices of musculoskeletal options and enabling applied sciences to affect the care continuum, now together with the procedurally built-in portfolio of NuVasive. The Firm’s staff are relentlessly targeted on advancing affected person care. For extra data, please go to www.globusmedical.com/uniting.
Secure Harbor Statements
All statements included on this press launch apart from statements of historic reality are forward-looking statements and could also be recognized by their use of phrases comparable to “consider,” “could,” “may,” “may,” “will,” “purpose,” “estimate,” “proceed,” “anticipate,” “intend,” “anticipate,” “plan” and different comparable phrases. These forward-looking statements are primarily based on our present assumptions, expectations and estimates of future occasions and developments. Ahead-looking statements are solely predictions and are topic to many dangers, uncertainties and different elements that will have an effect on our companies and operations and will trigger precise outcomes to vary materially from these predicted. These dangers and uncertainties embrace, however aren’t restricted to, the dangers and prices related to the mixing of, and the flexibility of Globus Medical and NuVasive to combine, their companies efficiently and to attain anticipated synergies, well being epidemics, pandemics and comparable outbreaks, together with the COVID-19 pandemic, elements affecting our quarterly outcomes, our means to handle our development, our means to maintain our profitability, demand for our merchandise, our means to compete efficiently (together with with out limitation our means to persuade surgeons to make use of our merchandise and our means to draw and retain gross sales and different personnel), our means to quickly develop and introduce new merchandise, our means to develop and execute on profitable enterprise methods, our means to adjust to legal guidelines and laws which might be or could turn into relevant to our companies, our means to safeguard our mental property, our success in defending authorized proceedings introduced towards us, developments within the medical system {industry}, normal financial circumstances, and different dangers. For a dialogue of those and different dangers, uncertainties and different elements that might have an effect on our outcomes, you must confer with the disclosure contained in our most up-to-date annual report on Type 10-Ok filed with the Securities and Alternate Fee, together with the sections labeled “Threat Components” and “Cautionary Observe Regarding Ahead-Trying Statements,” and in our Kinds 10-Q, Kinds 8-Ok and different filings with the Securities and Alternate Fee. These paperwork can be found at www.sec.gov. Furthermore, we function in an evolving setting. New threat elements and uncertainties emerge every so often and it isn’t doable for us to foretell all threat elements and uncertainties, nor can we assess the affect of all elements on our enterprise or the extent to which any issue, or mixture of things, could trigger precise outcomes to vary materially from these contained in any forward-looking statements. Given these dangers and uncertainties, readers are cautioned to not place undue reliance on any forward-looking statements. Ahead-looking statements contained on this press launch communicate solely as of the date of this press launch. We undertake no obligation to replace any forward-looking statements because of new data, occasions or circumstances or different elements arising or coming to our consideration after the date hereof.
Investor contact:
Brian Kearns
610-930-1800
buyers@globusmedical.com
Media contact:
Melanie Ordoñez
858-722-3899
media@globusmedical.com
Discussion about this post